Overview
- A securities class action has been filed alleging Phreesia made false or misleading statements about demand and the visibility of pharmaceutical marketing commitments during the May 8, 2025 to March 30, 2026 class period.
- The Rosen Law Firm and the Schall Law Firm issued public notices on June 4–5 asking eligible purchasers to join the case and to move for lead-plaintiff status by July 13, 2026.
- The complaint says investors suffered losses when the market learned the true state of Phreesia’s Network Solutions demand and weakened pharmaceutical marketing commitments.
- Potential class members can register with the plaintiff firms by phone, email, or the firms’ websites and may pursue recovery on a contingency-fee basis with no upfront legal fees.
- No class has been certified and the court will first decide which investor will serve as lead plaintiff and later rule on class certification, outcomes that will shape any eventual recovery for shareholders.